Unknown PHASE2 INTERVENTIONAL 2-arm NCT01214499

Prospective, Controlled and Randomized Clinical Trial on Cardiac Cell Regeneration With Laser and Autologous Bone Marrow Stem Cells, in Patients With Coronary Disease and Refractory Angina

Sponsor: Fundación de Investigación Biomédica - Hospital Universitario de La Princesa

Interventions Transmyocardial revascularization (TMR) with Holmium YAG laser Transmyocardial revascularization (TMR) with Holmium YAG laser plus the patient's own stem cells extracted from bone marrow.

Updated 5 times since 2017 Last updated: Nov 27, 2010 Started: Oct 31, 2010 Primary completion: Oct 31, 2012 Completion: Oct 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Angina and Coronary Disease and is currently ongoing. Fundación de Investigación Biomédica - Hospital Universitario de La Princesa leads this study, which shows 5 recorded versions since 2010 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

First recorded

Oct 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fundación de Investigación Biomédica - Hospital Universitario de La Princesa

Data source: Fundación de Investigación Biomédica - Hospital Universitario de La Princesa

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Madrid, Spain